Position in KROS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$350,478
-$93,065 QoQ
Shares Held
32,755
-18.5% QoQ
Ownership
0.165%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 131 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 21%
Shared 0%
None 79%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,404,724,682 across 329 Biotechnology names. KROS ranks #208 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in KROS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $350,478 | 32,755 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $443,543 | 40,176 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $900,624 | 44,235 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $798,561 | 50,478 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $691,730 | 51,815 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $455,177 | 44,669 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $646,924 | 40,867 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $2,350,441 | 40,476 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,902,856 | 41,638 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,285,687 | 34,527 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $1,258,682 | 31,657 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,037,470 | 32,543 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,324,051 | 32,953 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $1,199,485 | 28,091 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,266,959 | 26,384 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $878,690 | 23,357 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $559,535 | 20,251 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $863,880 | 15,886 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $813,406 | 13,902 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $561,158 | 14,185 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $573,557 | 13,505 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $841,696 | 13,675 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $960,119 | 13,611 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $270,877 | 7,023 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $293,853 | 7,834 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||